177 related articles for article (PubMed ID: 22903264)
1. Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.
Waaijer CJ; de Andrea CE; Hamilton A; van Oosterwijk JG; Stringer SE; Bovée JV
Virchows Arch; 2012 Oct; 461(4):475-81. PubMed ID: 22903264
[TBL] [Abstract][Full Text] [Related]
2. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
Lamanna WC; Frese MA; Balleininger M; Dierks T
J Biol Chem; 2008 Oct; 283(41):27724-27735. PubMed ID: 18687675
[TBL] [Abstract][Full Text] [Related]
3. Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling.
Gill RM; Mehra V; Milford E; Dhoot GK
Histochem Cell Biol; 2016 Oct; 146(4):431-44. PubMed ID: 27294358
[TBL] [Abstract][Full Text] [Related]
4. TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.
Shinohara N; Maeda S; Yahiro Y; Sakuma D; Matsuyama K; Imamura K; Kawamura I; Setoguchi T; Ishidou Y; Nagano S; Komiya S
Sci Rep; 2017 Oct; 7(1):13494. PubMed ID: 29044189
[TBL] [Abstract][Full Text] [Related]
5. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation.
Properzi F; Lin R; Kwok J; Naidu M; van Kuppevelt TH; Ten Dam GB; Camargo LM; Raha-Chowdhury R; Furukawa Y; Mikami T; Sugahara K; Fawcett JW
Eur J Neurosci; 2008 Feb; 27(3):593-604. PubMed ID: 18279312
[TBL] [Abstract][Full Text] [Related]
7. EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression.
Lin ZS; Chung CC; Liu YC; Chang CH; Liu HC; Liang YY; Huang TL; Chen TM; Lee CH; Tang CH; Hung MC; Chen YH
Elife; 2023 Jan; 12():. PubMed ID: 36622753
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
9. Expression of Sulf1 and Sulf2 in cartilage, bone and endochondral fracture healing.
Zaman G; Staines KA; Farquharson C; Newton PT; Dudhia J; Chenu C; Pitsillides AA; Dhoot GK
Histochem Cell Biol; 2016 Jan; 145(1):67-79. PubMed ID: 26464246
[TBL] [Abstract][Full Text] [Related]
10. Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation.
de Andrea CE; Wiweger MI; Bovée JV; Romeo S; Hogendoorn PC
Virchows Arch; 2012 Jan; 460(1):95-102. PubMed ID: 22116208
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
[TBL] [Abstract][Full Text] [Related]
13. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
14. De-differentiated chondrosarcoma is not a 'de-differentiated' chondrosarcoma.
Aigner T; Dertinger S; Neureiter D; Kirchner T
Histopathology; 1998 Jul; 33(1):11-9. PubMed ID: 9726043
[TBL] [Abstract][Full Text] [Related]
15. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain.
Frese MA; Milz F; Dick M; Lamanna WC; Dierks T
J Biol Chem; 2009 Oct; 284(41):28033-28044. PubMed ID: 19666466
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib causes growth arrest and inhibition of metastasis in human chondrosarcoma cells.
Song J; Zhu J; Zhao Q; Tian B
J BUON; 2015; 20(3):894-901. PubMed ID: 26214645
[TBL] [Abstract][Full Text] [Related]
18. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
19. Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors.
Ho L; Stojanovski A; Whetstone H; Wei QX; Mau E; Wunder JS; Alman B
Cancer Cell; 2009 Aug; 16(2):126-36. PubMed ID: 19647223
[TBL] [Abstract][Full Text] [Related]
20. Abl expression, tumour grade, and apoptosis in chondrosarcoma.
O'Donovan M; Russell JM; O'Leary JJ; Gillan JA; Lawler MP; Gaffney EF
Mol Pathol; 1999 Dec; 52(6):341-4. PubMed ID: 10748867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
